Caplin Point Laboratories Intrinsic Value
CAPLIPOINT Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1788.16 | ₹1430.53 - ₹2145.79 | +8.2% | EPS: ₹81.28, Sector P/E: 22x |
| Book Value Method | asset | ₹3848.00 | ₹3463.20 - ₹4232.80 | +132.7% | Book Value/Share: ₹1924.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹3008.00 | ₹2707.20 - ₹3308.80 | +81.9% | Revenue/Share: ₹1504.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹3306.60 | ₹2975.94 - ₹3637.26 | +100.0% | EBITDA: ₹880.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹3573.24 | ₹2858.59 - ₹4287.89 | +116.1% | CF Growth: 12.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹520.19 | ₹468.17 - ₹572.21 | -68.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1255.78 | ₹1130.20 - ₹1381.36 | -24.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹3306.60 | ₹2975.94 - ₹3637.26 | +100.0% | ROE: 22.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1875.80 | ₹1688.22 - ₹2063.38 | +13.5% | EPS: ₹81.28, BVPS: ₹1924.00 |
Want to compare with current market value? Check CAPLIPOINT share price latest .
Valuation Comparison Chart
CAPLIPOINT Intrinsic Value Analysis
What is the intrinsic value of CAPLIPOINT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Caplin Point Laboratories (CAPLIPOINT) is ₹3008.00 (median value). With the current market price of ₹1653.30, this represents a +81.9% variance from our estimated fair value.
The valuation range spans from ₹520.19 to ₹3848.00, indicating ₹520.19 - ₹3848.00.
Is CAPLIPOINT undervalued or overvalued?
Based on our multi-method analysis, Caplin Point Laboratories (CAPLIPOINT) appears to be trading below calculated value by approximately 81.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 133.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 22.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 35.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.70x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Caplin Point Laboratories
Additional stock information and data for CAPLIPOINT
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹432 Cr | ₹266 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹318 Cr | ₹159 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹271 Cr | ₹163 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹337 Cr | ₹149 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹269 Cr | ₹254 Cr | Positive Free Cash Flow | 8/10 |